Key facts
- Notable investors include GL Ventures, Oriental Fortune Capital, Suzhou Guofa Venture Capital, CMB International Capital, China Merchants Capital — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Vbiosci
- ·The full record, as it builds
Funding rounds
No funding rounds for Vbiosci are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vbiosci
Developer of culture medium and veterinary vaccines designed for the biological field. The company's culture medium and veterinary vaccines are based on the independently established vaccine research platform, antibody-drug research platform, and pilot expression platform, enabling veterinary businesses to have high-quality vaccines and antibody protein products.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2016
- Website
- vbiosci.com/
- Ownership
- Privately Held (backing)
Vbiosci doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vbiosci shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vbiosci in its N-PORT filings yet. We sweep new filings monthly.